Joinn Laboratories(China)Co.,Ltd. Stock
Equities
603127
CNE100002W27
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.21 CNY | +4.84% | +7.31% | -23.20% |
Sales 2024 * | 2.41B 333M | Sales 2025 * | 2.88B 398M | Capitalization | 12.55B 1.73B |
---|---|---|---|---|---|
Net income 2024 * | 514M 70.97M | Net income 2025 * | 673M 92.93M | EV / Sales 2024 * | 3.68 x |
Net cash position 2024 * | 3.3B 455M | Net cash position 2025 * | 3.52B 487M | EV / Sales 2025 * | 3.14 x |
P/E ratio 2024 * |
26.6
x | P/E ratio 2025 * |
20.6
x | Employees | 2,510 |
Yield 2024 * |
0.93% | Yield 2025 * |
1.1% | Free-Float | 58.77% |
1 day | +4.84% | ||
1 week | +7.31% | ||
Current month | +0.72% | ||
1 month | +0.72% | ||
3 months | +1.51% | ||
6 months | -26.42% | ||
Current year | -23.20% |
Managers | Title | Age | Since |
---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 42 | 12-10-31 |
Ai Shui Yu
DFI | Director of Finance/CFO | 48 | 19-06-30 |
Ye Li
CHM | Chairman | 42 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yu Xia Feng
FOU | Founder | 60 | 95-08-10 |
Cong Lin Zuo
BRD | Director/Board Member | 60 | 96-11-30 |
Yun Xia Sun
BRD | Director/Board Member | 56 | 99-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.46% | 2 M€ | -14.86% | - | |
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 18.21 | +4.84% | 20,446,120 |
24-04-26 | 17.37 | +2.72% | 18,670,250 |
24-04-25 | 16.91 | -0.82% | 11,812,820 |
24-04-24 | 17.05 | -2.57% | 13,013,380 |
24-04-23 | 17.5 | +3.12% | 16,251,100 |
End-of-day quote Shanghai S.E., April 28, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.20% | 1.73B | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- 603127 Stock